发明名称 |
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
摘要 |
Provided herein are Aminopurine Compounds having the following structure:;wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof. |
申请公布号 |
US9187479(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US201414225831 |
申请日期 |
2014.03.26 |
申请人 |
Signal Pharmaceuticals, LLC |
发明人 |
Clareen Steven;Plantevin-Krenitsky Veronique;Palanki Moorthy;Satoh Yoshitaka |
分类号 |
C07D473/32;A61K31/52;A61P35/00 |
主分类号 |
C07D473/32 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A compound having the formula (I): or a pharmaceutically acceptable salt thereof, wherein: R1 is substituted or unsubstituted C3-10heterocycle; R2 is cyclohexyl substituted with one or more hydroxyl, cyano, tetrazolyl, triazolyl or imidazolyl groups; and R3 is aryl substituted with one or more halogens. |
地址 |
San Diego CA US |